IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
5.96
-1.06 (-15.10%)
At close: Jun 26, 2026, 4:00 PM EDT
5.83
-0.13 (-2.18%)
After-hours: Jun 26, 2026, 7:59 PM EDT
IceCure Medical Revenue
IceCure Medical had revenue of $911.00K in the quarter ending March 31, 2026, with 25.66% growth. This brings the company's revenue in the last twelve months to $3.57M, up 8.92% year-over-year. In the year 2025, IceCure Medical had annual revenue of $3.38M with 2.67% growth.
Revenue (ttm)
$3.57M
Revenue Growth
+8.92%
P/S Ratio
4.69
Revenue / Employee
$51,667
Employees
69
Market Cap
16.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.38M | 88.00K | 2.67% |
| Dec 31, 2024 | 3.29M | 62.00K | 1.92% |
| Dec 31, 2023 | 3.23M | 144.00K | 4.67% |
| Dec 31, 2022 | 3.09M | -1.05M | -25.45% |
| Dec 31, 2021 | 4.14M | 270.00K | 6.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TELA Bio | 80.81M |
| IRIDEX | 52.58M |
| Cytosorbents | 37.20M |
| Baird Medical Investment Holdings | 22.54M |
| Lifeward | 20.92M |
| NeuroOne Medical Technologies | 12.72M |
| InspireMD | 10.85M |
| Picard Medical | 5.47M |
ICCM News
- 1 day ago - IceCure Medical registers to sell 5.5M ordinary shares for holders - TheFly
- 1 day ago - IceCure Medical regains compliance with Nasdaq minimum bid price requirement - TheFly
- 1 day ago - IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 1 day ago - IceCure Medical Registration statement: Registration filing - Filings
- 3 days ago - IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer - PRNewsWire
- 4 days ago - Icecure Medical Ltd trading resumes - TheFly
- 4 days ago - Icecure Medical Ltd trading halted, volatility trading pause - TheFly
- 9 days ago - Why Is IceCure Medical Stock (ICCM) Up Today? - TipRanks